Adel Chergui

437 total citations
16 papers, 385 citations indexed

About

Adel Chergui is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Adel Chergui has authored 16 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Adel Chergui's work include Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (3 papers). Adel Chergui is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (3 papers). Adel Chergui collaborates with scholars based in United States and Japan. Adel Chergui's co-authors include Yves Pommier, Christophe Marchand, Mark Cushman, Keli Agama, Andrew G. Stephen, Andrew Morrell, Martin Conda‐Sheridan, Amèlie Renaud, Barry R. O’Keefe and Junko Murai and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Adel Chergui

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adel Chergui United States 9 283 155 97 71 51 16 385
Monica Abdelmalak United States 9 282 1.0× 166 1.1× 83 0.9× 54 0.8× 54 1.1× 9 375
Nikhil Reddy Madadi United States 13 195 0.7× 339 2.2× 60 0.6× 25 0.4× 47 0.9× 26 550
C. Caroline O’Hare United Kingdom 14 377 1.3× 185 1.2× 101 1.0× 54 0.8× 22 0.4× 24 525
Zizhao Guo China 9 229 0.8× 248 1.6× 132 1.4× 36 0.5× 24 0.5× 11 403
Mark D. Prairie United States 9 358 1.3× 162 1.0× 71 0.7× 70 1.0× 56 1.1× 21 438
Lingjian Zhu China 12 196 0.7× 218 1.4× 116 1.2× 56 0.8× 21 0.4× 19 358
Rajesh Kakadiya Taiwan 16 335 1.2× 506 3.3× 86 0.9× 37 0.5× 35 0.7× 35 695
Irina Chuckowree United Kingdom 9 289 1.0× 221 1.4× 206 2.1× 45 0.6× 21 0.4× 13 504
Antonella Pepe United States 13 264 0.9× 228 1.5× 108 1.1× 13 0.2× 52 1.0× 25 550
Wieslaw M. Cholody United States 11 396 1.4× 246 1.6× 139 1.4× 106 1.5× 21 0.4× 24 532

Countries citing papers authored by Adel Chergui

Since Specialization
Citations

This map shows the geographic impact of Adel Chergui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Chergui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Chergui more than expected).

Fields of papers citing papers by Adel Chergui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Chergui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Chergui. The network helps show where Adel Chergui may publish in the future.

Co-authorship network of co-authors of Adel Chergui

This figure shows the co-authorship network connecting the top 25 collaborators of Adel Chergui. A scholar is included among the top collaborators of Adel Chergui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel Chergui. Adel Chergui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chergui, Adel & John L. Reagan. (2023). Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress. Cancers. 15(16). 4137–4137. 8 indexed citations
2.
Tolu, Seda S., et al.. (2022). Survival analysis of patients with early and standard onset colorectal cancer: A single center study.. Journal of Clinical Oncology. 40(16_suppl). e15512–e15512. 1 indexed citations
3.
Chergui, Adel, Seda S. Tolu, Devika Rao, et al.. (2021). Racial ethnic disparities in clinical/pathological features, treatment, and survival among patients with early-onset colorectal cancer.. Journal of Clinical Oncology. 39(3_suppl). 21–21. 1 indexed citations
4.
Chergui, Adel, Seda S. Tolu, Ana Acuña-Villaorduña, et al.. (2020). Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study.. Journal of Clinical Oncology. 38(4_suppl). 557–557. 1 indexed citations
5.
Sukrithan, Vineeth, Adel Chergui, Brian Ko, et al.. (2019). Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non–Small Cell Lung Cancer. American Journal of Clinical Oncology. 43(1). 64–68. 2 indexed citations
6.
Bermingham, Alun, Edmund V. Price, Christophe Marchand, et al.. (2017). Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1). SLAS DISCOVERY. 22(9). 1093–1105. 19 indexed citations
7.
Marchand, Christophe, Shar-yin N. Huang, Thomas S. Dexheimer, et al.. (2014). Biochemical Assays for the Discovery of TDP1 Inhibitors. Molecular Cancer Therapeutics. 13(8). 2116–2126. 17 indexed citations
8.
Murai, Junko, Christophe Marchand, Sampada A. Shahane, et al.. (2014). Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform. DNA repair. 21. 177–182. 20 indexed citations
9.
Patel, Maulik, Jamin D. Steffen, Adel Chergui, et al.. (2014). Discovery and Structure–Activity Relationship of Novel 2,3-Dihydrobenzofuran-7-carboxamide and 2,3-Dihydrobenzofuran-3(2H)-one-7-carboxamide Derivatives as Poly(ADP-ribose)polymerase-1 Inhibitors. Journal of Medicinal Chemistry. 57(13). 5579–5601. 48 indexed citations
10.
11.
Morrell, Andrew, Martin Conda‐Sheridan, Christophe Marchand, et al.. (2012). Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)–Topoisomerase I (Top1) Inhibitors. Journal of Medicinal Chemistry. 55(9). 4457–4478. 81 indexed citations
12.
Conda‐Sheridan, Martin, P. Venkat Reddy, Andrew Morrell, et al.. (2012). Synthesis and Biological Evaluation of Indenoisoquinolines That Inhibit Both Tyrosyl-DNA Phosphodiesterase I (Tdp1) and Topoisomerase I (Top1). Journal of Medicinal Chemistry. 56(1). 182–200. 67 indexed citations
13.
Sirivolu, Venkata Ramana, Sanjeev Kumar V. Vernekar, Christophe Marchand, et al.. (2012). 5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl–DNA Phosphodiesterase I. Journal of Medicinal Chemistry. 55(20). 8671–8684. 55 indexed citations
14.
Saliba, Ethan N., et al.. (1987). [Ultrasonic diagnosis and follow-up of aneurysms of the ampulla of Galen in infants].. PubMed. 33(4). 291–5. 1 indexed citations
15.
Saliba, Ethan N., et al.. (1985). [Echographic monitoring of post-hemorrhagic ventricular dilatations in premature newborn infants. Value of the determination of a ventricular index].. PubMed. 42(4). 281–4. 1 indexed citations
16.
Arbeille, Philippe, et al.. (1985). [Non invasive measurement of the cerebral blood flow in infants with hydrocephalus].. PubMed. 42(2). 97–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Abdelmalak Breakdown of academic impact, for papers by Nikhil Reddy Madadi Breakdown of academic impact, for papers by C. Caroline O’Hare Breakdown of academic impact, for papers by Zizhao Guo Breakdown of academic impact, for papers by Mark D. Prairie Breakdown of academic impact, for papers by Lingjian Zhu Breakdown of academic impact, for papers by Rajesh Kakadiya Breakdown of academic impact, for papers by Irina Chuckowree Breakdown of academic impact, for papers by Antonella Pepe Breakdown of academic impact, for papers by Wieslaw M. Cholody
Rankless by CCL
2026